Drug intelligence / Profile preview

fecal microbiota transplantation (Fuwai Hospital)

Development stage: Unknown
Lead developer: Chinese Academy of Medical Sciences
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Fecal microbiota transplantation (FMT) developed by the Chinese Academy of Medical Sciences and Fuwai Hospital is an investigational biologic intervention for the treatment of primary hypertension. [3-5, 5-8] It is administered as oral capsules containing gut microbiota derived from healthy donors. [3-5, 5-8] The therapeutic hypothesis is that restoring gut microbiome dysbiosis, which has been linked to the development of hypertension, can lead to a reduction in blood pressure. [3-10] A multicenter, randomized, blinded, placebo-controlled clinical trial (NCT04406129) was conducted in China to evaluate the efficacy and safety of this intervention in patients with grade 1 hypertension. [3-11, 5-8, 5-11]

Other names: fecal microbiota transplantFMT

Beyond the preview

Go deeper on fecal microbiota transplantation (Fuwai Hospital).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on fecal microbiota transplantation (Fuwai Hospital).

Explore the full profile